EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model

Andreas Winter iD, Pascal Nepper iD, Marcus Hermann iD, Franziska Bayer, Stephanie Riess, Razan Salem iD, Jan Hlavicka iD, Anatol Prinzing, Florian Hecker, Tomas Holubec iD, Kai Zacharowski, Thomas Walther und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Andreas Winter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, University Hospital Frankfurt, Goethe University, 60629 Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Glyburide, Cardiopulmonary Bypass, Vasoconstrictor Agents, Vasoplegia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hemodynamic stabilization of patients after complex cardiac surgery is a daily challenge. The use of high doses of catecholamines is common but has potential adverse effects. Glibenclamide, a KATP blocker, seems to attenuate vasoplegia in different animal models of septic shock. Therefore, the aim of this study was to investigate the impact of Glibenclamide on the vasoplegic syndrome after cardiopulmonary bypass in a porcine model. In this experimental study, 20 landrace pigs were randomized into two groups and examined: In the control group, standard medical therapy, including norepinephrine, was used, and in the study group standard medical therapy plus additional Glibenclamide was administered. Following general anesthesia, prolonged cardiopulmonary bypass and aortic cross-clamping was performed. In the study group, Glibenclamide was administered 45 min after weaning from cardiopulmonary bypass. The dosage used was 10 mg/kg as a bolus, followed by a continuous infusion of 10 mg/kg/h. Hemodynamic and laboratory measurements were performed. Glibenclamide had a relevant effect on circulatory parameters. With increasing vascular resistance and blood pressure, norepinephrine was able to be reduced. While the heart rate dropped to physiological levels, the cardiac index decreased as well. The results lead to the conclusion that Glibenclamide was able to break through vasoplegic syndrome and could therefore serve as a potent drug to stabilize patients after cardiac surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlyburideCardiopulmonary BypassVasoconstrictor AgentsVasoplegiaAnimalsSwineDisease Models, AnimalHemodynamicsNorepinephrineBlood Pressure

Stichwörter der Autor:innen

Glibenclamidecardiopulmonary bypassreperfusion

Substanzen

GlyburideVasoconstrictor AgentsNorepinephrine

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, University Hospital Frankfurt, Goethe University, 60629 Frankfurt am Main, Germany.
  • Central Research Unit, Goethe University Frankfurt, 60629 Frankfurt am Main, Germany.
  • Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, 60629 Frankfurt am Main, Germany.
  • Department of Cardiovascular and Thoracic Surgery, University Hospital Augsburg, 86156 Augsburg, Germany.

ORCID-Profile: Andreas Winter, Pascal Nepper, Marcus Hermann, Razan Salem, Jan Hlavicka, Tomas Holubec

Zitieren

APA

Winter, A., Nepper, P., Hermann, M., Bayer, F., Riess, S., Salem, R., Hlavicka, J., Prinzing, A., Hecker, F., Holubec, T., Zacharowski, K., Walther, T., & Emrich, F. (2025). Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094040

Vancouver

Winter A, Nepper P, Hermann M, Bayer F, Riess S, Salem R, et al. Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094040

BibTeX
@article{Winter2025,
  author = {Winter, Andreas and Nepper, Pascal and Hermann, Marcus and Bayer, Franziska and Riess, Stephanie and Salem, Razan and Hlavicka, Jan and Prinzing, Anatol and Hecker, Florian and Holubec, Tomas and Zacharowski, Kai and Walther, Thomas and Emrich, Fabian},
  title = {Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094040}
}
Kostenlos starten →